Advances in the diagnosis and management of IgG4 related disease

M Lanzillotta, G Mancuso, E Della-Torre - Bmj, 2020 - bmj.com
IgG4 related disease was recognized as a unified disease entity only 15 years ago.
Awareness of IgG4 related disease has increased worldwide since then, and specialists are …

The family of the interleukin‐1 receptors

D Boraschi, P Italiani, S Weil… - Immunological reviews, 2018 - Wiley Online Library
The extracellular forms of the IL‐1 cytokines are active through binding to specific receptors
on the surface of target cells. IL‐1 ligands bind to the extracellular portion of their ligand …

Circulating levels of IL-1 family cytokines and receptors in Alzheimer's disease: new markers of disease progression?

P Italiani, I Puxeddu, S Napoletano, E Scala… - Journal of …, 2018 - Springer
Background Although the mechanisms underlying AD neurodegeneration are not fully
understood, it is now recognised that inflammation could play a crucial role in the initiation …

Emerging therapy options for IgG4-related disease

M Lanzillotta, A Fernàndez-Codina… - Expert Review of …, 2021 - Taylor & Francis
ABSTRACT Introduction Awareness of IgG4-related disease (IgG4-RD) is increasing
worldwide and specialists are now familiar with most of its clinical manifestations and …

Allergic aspects of IgG4-related disease: implications for pathogenesis and therapy

D Michailidou, DM Schwartz, T Mustelin… - Frontiers in …, 2021 - frontiersin.org
IgG4-related disease (IgG4-RD) is a rare systemic fibroinflammatory disease frequently
associated with allergy. The pathogenesis of IgG4-RD is poorly understood, and effective …

Regulation of IL-1 signaling by the decoy receptor IL-1R2

T Schlüter, C Schelmbauer, K Karram… - Journal of Molecular …, 2018 - Springer
The pleiotropic cytokine IL-1 mediates its biological functions via association with the
signaling receptor IL-1R1. Despite an apparent simplicity in IL-1 signaling activation …

Expression of USP25 associates with fibrosis, inflammation and metabolism changes in IgG4-related disease

P Jiang, Y Jing, S Zhao, C Lan, L Yang, X Dai… - Nature …, 2024 - nature.com
Abstract IgG4-related disease (IgG4-RD) has complex clinical manifestations ranging from
fibrosis and inflammation to deregulated metabolism. The molecular mechanisms …

[PDF][PDF] The treatment outcomes in IgG4-related disease

AF Karim, RD Bansie, SM Rombach, D Paridaens… - Neth J Med, 2018 - njmonline.nl
ABSTRACT Introduction: IgG4-related disease (IgG4-RD) is an emerging systemic
inflammatory disease involving nearly all organs eventually leading to fibrosis. Prompt and …

Soluble Interleukin‐2 receptor: a potential marker for monitoring disease activity in IgG4‐related disease

AF Karim, LEM Eurelings, RD Bansie… - Mediators of …, 2018 - Wiley Online Library
Background. IgG4‐related disease (IgG4‐RD) is a fibroinflammatory condition. T‐cells play
a crucial role in the pathogenesis, and therefore, serum soluble interleukin‐2 receptor (sIL …

Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partners

L Iaccarino, R Talarico… - Clinical and …, 2022 - research.unipd.it
Immunoglobulin G4 (IgG4)-related disease (IgG4-RD) is a chronic, clinically heterogenous
fibroinflammatory condition, characterised by an accumulation of IgG4 secreting plasma …